Medicaid AMP Final Rule Expected This Month, Draft 340B Rule In July
This article was originally published in The Pink Sheet Daily
Executive Summary
Two rules eagerly awaited by the biopharma industry are targeted for release in the next two months, according to the latest regulatory agenda for HHS: the final rule on calculating the Medicaid average manufacturer price for drugs in June and the proposed rule on 340B program regulations in July.